DGX

SEC source: 0001022079-25-000075 · wk-form4_1740778717.xml · nonDerivative · entry 1

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 138,215

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

SEC source: 0001022079-25-000074 · wk-form4_1740778674.xml · nonDerivative · entry 1

PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 39,559

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

SEC source: 0001022079-25-000073 · wk-form4_1740778616.xml · nonDerivative · entry 1

Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,853

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

SEC source: 0001022079-25-000072 · wk-form4_1740778570.xml · nonDerivative · entry 1

KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,546

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

SEC source: 0001022079-25-000071 · wk-form4_1740778491.xml · nonDerivative · entry 1

Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 70,002

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

SEC source: 0001022079-25-000070 · wk-form4_1740778439.xml · nonDerivative · entry 1

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,212

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

SEC source: 0001022079-25-000069 · wk-form4_1740778392.xml · nonDerivative · entry 1

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,983

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

SEC source: 0001022079-25-000058 · wk-form4_1740174264.xml · nonDerivative · entry 2

PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 39,845

F2 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

SEC source: 0001022079-25-000052 · wk-form4_1740174056.xml · nonDerivative · entry 2

Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 70,457

F2 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

SEC source: 0001022079-25-000046 · wk-form4_1740173800.xml · nonDerivative · entry 1

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 141,181

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

SEC source: 0001022079-25-000060 · wk-form4_1740174343.xml · nonDerivative · entry 1

SAMAD SAM · CIK 0001694295 · Executive Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,046

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

SEC source: 0001022079-25-000058 · wk-form4_1740174264.xml · nonDerivative · entry 1

PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,449

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

SEC source: 0001022079-25-000056 · wk-form4_1740174188.xml · nonDerivative · entry 1

Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,082

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

SEC source: 0001022079-25-000054 · wk-form4_1740174125.xml · nonDerivative · entry 1

KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,779

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

SEC source: 0001022079-25-000052 · wk-form4_1740174056.xml · nonDerivative · entry 1

Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 71,356

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

SEC source: 0001022079-25-000050 · wk-form4_1740173971.xml · nonDerivative · entry 1

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,300

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

SEC source: 0001022079-25-000048 · wk-form4_1740173866.xml · nonDerivative · entry 1

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,197

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

SEC source: 0001022079-25-000038 · wk-form4_1739572222.xml · derivative · entry 2

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,633

Underlying: Common Stock · 69,633 shares

Expires 2035-02-12

F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.

SEC source: 0001022079-25-000038 · wk-form4_1739572222.xml · nonDerivative · entry 1

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144,117

F1 · security: Represents an award of restricted stock units.

SEC source: 0001022079-25-000037 · wk-form4_1739572188.xml · derivative · entry 2

SAMAD SAM · CIK 0001694295 · Executive Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,403

Underlying: Common Stock · 17,403 shares

Expires 2035-02-12

F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.

SEC source: 0001022079-25-000037 · wk-form4_1739572188.xml · nonDerivative · entry 1

SAMAD SAM · CIK 0001694295 · Executive Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,077

F1 · security: Represents an award of restricted stock units.

SEC source: 0001022079-25-000036 · wk-form4_1739572153.xml · derivative · entry 3

PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,991

Underlying: Common Stock · 8,991 shares

Expires 2035-02-12

F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.

SEC source: 0001022079-25-000036 · wk-form4_1739572153.xml · nonDerivative · entry 1

PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,823

F1 · security: Represents an award of restricted stock units.

SEC source: 0001022079-25-000035 · wk-form4_1739572111.xml · derivative · entry 2

Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,833

Underlying: Common Stock · 7,833 shares

Expires 2035-02-12

F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.

SEC source: 0001022079-25-000035 · wk-form4_1739572111.xml · nonDerivative · entry 1

Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,402

F1 · security: Represents an award of restricted stock units.

F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.

SEC source: 0001022079-25-000034 · wk-form4_1739572073.xml · derivative · entry 4

KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,702

Underlying: Common Stock · 8,702 shares

Expires not disclosed

F4 · derivative.expiration_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.

SEC source: 0001022079-25-000034 · wk-form4_1739572073.xml · nonDerivative · entry 1

KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,066

F1 · security: Represents an award of restricted stock units.

F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the reporting person's last filing on Form 4.

SEC source: 0001022079-25-000033 · wk-form4_1739572041.xml · derivative · entry 3

Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,344

Underlying: Common Stock · 13,344 shares

Expires 2035-02-12

F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.

SEC source: 0001022079-25-000033 · wk-form4_1739572041.xml · nonDerivative · entry 1

Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,891

F1 · security: Represents an award of restricted stock units.

SEC source: 0001022079-25-000032 · wk-form4_1739572003.xml · derivative · entry 2

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,960

Underlying: Common Stock · 6,960 shares

Expires 2035-02-12

F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.

SEC source: 0001022079-25-000032 · wk-form4_1739572003.xml · nonDerivative · entry 1

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,439

F1 · security: Represents an award of restricted stock units.

SEC source: 0001022079-25-000031 · wk-form4_1739571963.xml · derivative · entry 3

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,738

Underlying: Common Stock · 1,738 shares

Expires 2035-02-12

F4 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.

SEC source: 0001022079-25-000031 · wk-form4_1739571963.xml · nonDerivative · entry 1

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,399

F1 · security: Represents an award of restricted stock units.

F2 · balance_after: This amount includes previous exempt purchases made under the Company's stock purchase plan (the "plan") that were transferred out of the plan and into a brokerage account held by Reporting Person since the date of the last filing on Form 4.

SEC source: 0001022079-25-000022 · wk-form4_1738964245.xml · nonDerivative · entry 1

Gregg Vicky B · CIK 0001510304 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,867

SEC source: 0001022079-25-000020 · wk-form4_1738964173.xml · nonDerivative · entry 1

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,624

SEC source: 0001022079-25-000018 · wk-form4_1738359071.xml · nonDerivative · entry 1

Gregg Vicky B · CIK 0001510304 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,117

F1 · shares: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.

SEC source: 0001022079-25-000017 · wk-form4_1738359038.xml · nonDerivative · entry 1

SAMAD SAM · CIK 0001694295 · Executive Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,539

F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

SEC source: 0001022079-25-000016 · wk-form4_1738359001.xml · nonDerivative · entry 1

Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,345

F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.

SEC source: 0001022079-25-000015 · wk-form4_1738358968.xml · nonDerivative · entry 1

KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,780

F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the reporting person's last filing on Form 4.

SEC source: 0001022079-25-000014 · wk-form4_1738358926.xml · nonDerivative · entry 1

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,027

F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

SEC source: 0001022079-25-000003 · wk-form4_1736200076.xml · derivative · entry 1

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 190

Underlying: Common Stock · 190 shares

Expires not disclosed

F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.

F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.

SEC source: 0001022079-25-000004 · wk-form4_1736200137.xml · derivative · entry 1

RING TIMOTHY M · CIK 0001204666 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,081.414

Underlying: Common Stock · 281 shares

Expires not disclosed

F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.

F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.

F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.

SEC source: 0001022079-24-000208 · wk-form4_1733175791.xml · derivative · entry 5

PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 35,146 shares

Expires 2029-02-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F5 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.

SEC source: 0001022079-24-000208 · wk-form4_1733175791.xml · nonDerivative · entry 3

PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,478

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F3 · price: This transaction was executed in multiple trades at prices ranging from $162.705 to $163.615. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-24-000208 · wk-form4_1733175791.xml · nonDerivative · entry 2

PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,615

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $161.690 to $162.680. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-24-000208 · wk-form4_1733175791.xml · nonDerivative · entry 1

PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,624

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

SEC source: 0001022079-24-000206 · wk-form4_1733175712.xml · derivative · entry 5

Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 33,103 shares

Expires 2028-02-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F5 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.

SEC source: 0001022079-24-000206 · wk-form4_1733175712.xml · nonDerivative · entry 3

Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,412

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F3 · price: This transaction was executed in multiple trades at prices ranging from $162.815 to $163.790. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-24-000206 · wk-form4_1733175712.xml · nonDerivative · entry 2

Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,712

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $161.790 to $162.785. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-24-000206 · wk-form4_1733175712.xml · nonDerivative · entry 1

Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,515

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.